Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Journal of internal medicine·2017

Macrophage erythrophagocytosis and iron exocytosis.

Redox report : communications in free radical research·2016

HDL and LDL as therapeutic targets for cardiovascular disease prevention: the possible role of niacin.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2010

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.

Journal of internal medicine·2010

Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time.

Acta neurologica Scandinavica·2009

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

International journal of clinical practice·2009

The public health challenges of children's and adolescents' digital media use: applying the digital determinants of health as an interpretive framework.

Lancet (London, England)·2026

Governing the digital determinants of health for children and young people: a global public health imperative.

Lancet (London, England)·2026

The digital determinants of health: a new era for global public health.

Lancet (London, England)·2026

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Liver X receptor (LXR) signaling in macrophage inflammation and cardiometabolic disease.

Cardiovascular research·2026

Serum periostin as a novel biomarker of metabolic and atherogenic risk in newly diagnosed type 2 diabetes mellitus with dyslipidemia.

Journal of diabetes and metabolic disorders·2026

Cold exposure-induced alterations in n-3 fatty acid profiles and their associations with brown adipose tissue activity.

Endocrine journal·2026

ASSOCIATION BETWEEN INFLAMMATORY MARKERS, LIVER ENZYMES, LIPID PROFILE, AND VITAMIN D STATUS IN ADULTS WITH OBESITY: A CROSS-SECTIONAL STUDY.

Georgian medical news·2026

Assessment of the effect of fibroscan and anthropometric factors on incidence and progression of non-diabetic metabolic Dysfunction-associated steatotic liver disease.

Journal of the National Medical Association·2026

Biallelic ABCG8 Variants or Biochemical Evidence of Sitosterolemia: A Case Report.

Cureus·2026

Related Experiment Videos

Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation

Related Concept Videos

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Macrophage erythrophagocytosis and iron exocytosis.

HDL and LDL as therapeutic targets for cardiovascular disease prevention: the possible role of niacin.

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.

Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time.

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

The public health challenges of children's and adolescents' digital media use: applying the digital determinants of health as an interpretive framework.

Governing the digital determinants of health for children and young people: a global public health imperative.

The digital determinants of health: a new era for global public health.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Liver X receptor (LXR) signaling in macrophage inflammation and cardiometabolic disease.

Serum periostin as a novel biomarker of metabolic and atherogenic risk in newly diagnosed type 2 diabetes mellitus with dyslipidemia.

Cold exposure-induced alterations in n-3 fatty acid profiles and their associations with brown adipose tissue activity.

ASSOCIATION BETWEEN INFLAMMATORY MARKERS, LIVER ENZYMES, LIPID PROFILE, AND VITAMIN D STATUS IN ADULTS WITH OBESITY: A CROSS-SECTIONAL STUDY.

Assessment of the effect of fibroscan and anthropometric factors on incidence and progression of non-diabetic metabolic Dysfunction-associated steatotic liver disease.

Biallelic ABCG8 Variants or Biochemical Evidence of Sitosterolemia: A Case Report.

Related Experiment Videos

Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation...

Related Concept Videos

Related Articles

Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation